Workflow
南向资金抢筹医药生物板块！恒生创新药ETF（520500）周净流入额创近三月新高
Mei Ri Jing Ji Xin Wen·2025-08-18 04:34

Group 1 - The overall performance of the Hong Kong stock market is positive, with the innovative drug sector continuing its strong performance from the previous week, supported by solid fundamentals and high trading sentiment [1] - Southbound funds net bought HK stocks worth HKD 35.876 billion on August 15, setting a new record for single-day net inflow since the launch of the mutual market access mechanism in November 2014, with the innovative drug sector receiving a net inflow of HKD 1.042 billion [1] - The Hang Seng Innovative Drug ETF (520500) attracted a net inflow of HKD 117 million from August 11 to August 15, marking the highest weekly net inflow in nearly three months, and its total size reached HKD 1.351 billion, with a year-to-date increase of over 1000% [1] Group 2 - The Hang Seng Innovative Drug ETF (520500) closely tracks the Hang Seng Innovative Drug Index, which selects listed companies in the Hong Kong market related to innovative drug research, development, and production, emphasizing the exclusion of companies primarily engaged in the CXO industry [2] - The index's top five constituent stocks as of August 15 include BeiGene, CanSino Biologics, Innovent Biologics, China National Pharmaceutical Group, and Kelun-Biotech [2] - The national medical security work mid-year meeting held on August 15 emphasized empowering the pharmaceutical industry innovation and implementing measures to support high-quality development of innovative drugs, indicating continued policy support for the innovative drug sector [2] Group 3 - The manager of the Hang Seng Innovative Drug ETF (520500), Huatai-PB Fund, is one of the first ETF managers in China, known for creating leading ETFs such as the CSI 300 ETF and A500 ETF, maintaining an 18-year record of zero errors in ETF operations [3] - As of August 15, the size of the CSI 300 ETF is CNY 393.42 billion, and the A500 ETF is CNY 20.113 billion [3] - The Hang Seng Innovative Drug ETF (520500) was established on December 16, 2024, and supports T+0 trading, enhancing its liquidity advantage [3]